Autologous Blood Treatment for Ocular Surface Disease
Condition(s):Ocular Surface DiseaseLast Updated:April 15, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Ocular Surface DiseaseLast Updated:April 15, 2022Completed
Condition(s):Dry Eye Syndrome; Ocular Surface DiseaseLast Updated:April 24, 2020Completed
Condition(s):Orbital Neoplasms; Conjunctival Neoplasms; Eye NeoplasmsLast Updated:October 17, 2023Recruiting
Condition(s):Hemodialysis; Ocular Surface Disease; Dry Eye; OSDILast Updated:April 19, 2022Completed
Condition(s):Ocular Surface Disease; Dry Eye SyndromesLast Updated:October 29, 2020Unknown status
Condition(s):Ocular Surface Disease; Glaucoma, Open-AngleLast Updated:June 30, 2020Completed
Condition(s):Age-related CataractLast Updated:December 5, 2023Recruiting
Condition(s):Ocular Surface DiseaseLast Updated:February 28, 2017Withdrawn
Condition(s):Ocular SurfaceLast Updated:January 28, 2020Unknown status
Condition(s):Ocular Surface MicrobiomeLast Updated:September 6, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.